Geode Capital Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.5M | Sell |
2,934,815
-350,067
| -11% | -$7.45M | ﹤0.01% | 1307 |
|
|
2025
Q1 | $63.4M | Buy |
3,284,882
+84,035
| +3% | +$1.62M | 0.01% | 1235 |
|
|
2024
Q4 | $57.1M | Buy |
3,200,847
+101,039
| +3% | +$1.8M | ﹤0.01% | 1347 |
|
|
2024
Q3 | $67.9M | Buy |
3,099,808
+135,981
| +5% | +$2.98M | 0.01% | 1243 |
|
|
2024
Q2 | $23.1M | Sell |
2,963,827
-188,563
| -6% | -$1.47M | ﹤0.01% | 1851 |
|
|
2024
Q1 | $13.1M | Buy |
3,152,390
+66,724
| +2% | +$276K | ﹤0.01% | 2160 |
|
|
2023
Q4 | $8.05M | Buy |
3,085,666
+128,603
| +4% | +$336K | ﹤0.01% | 2453 |
|
|
2023
Q3 | $5.53M | Buy |
2,957,063
+277,754
| +10% | +$519K | ﹤0.01% | 2585 |
|
|
2023
Q2 | $6.73M | Buy |
2,679,309
+1,590,328
| +146% | +$3.99M | ﹤0.01% | 2535 |
|
|
2023
Q1 | $1.91M | Buy |
1,088,981
+617,308
| +131% | +$1.08M | ﹤0.01% | 3051 |
|
|
2022
Q4 | $2M | Buy |
471,673
+147,381
| +45% | +$626K | ﹤0.01% | 3037 |
|
|
2022
Q3 | $385K | Buy |
324,292
+269,937
| +497% | +$320K | ﹤0.01% | 3867 |
|
|
2022
Q2 | $54K | Sell |
54,355
-202,701
| -79% | -$201K | ﹤0.01% | 4758 |
|
|
2022
Q1 | $629K | Buy |
257,056
+8,235
| +3% | +$20.2K | ﹤0.01% | 3829 |
|
|
2021
Q4 | $669K | Sell |
248,821
-2,665
| -1% | -$7.17K | ﹤0.01% | 3899 |
|
|
2021
Q3 | $1.26M | Buy |
251,486
+29,893
| +13% | +$150K | ﹤0.01% | 3567 |
|
|
2021
Q2 | $1.65M | Buy |
221,593
+176,378
| +390% | +$1.32M | ﹤0.01% | 3346 |
|
|
2021
Q1 | $265K | Buy |
45,215
+25,804
| +133% | +$151K | ﹤0.01% | 4027 |
|
|
2020
Q4 | $91K | Hold |
19,411
| – | – | ﹤0.01% | 4071 |
|
|
2020
Q3 | $66K | Hold |
19,411
| – | – | ﹤0.01% | 3975 |
|
|
2020
Q2 | $57K | Buy |
+19,411
| New | +$57K | ﹤0.01% | 3959 |
|